Stock Track | YIDU TECH Soars 5.50% as Company Showcases AI-Driven Clinical Research Solutions at T20+ Conference

Stock Track

Aug 15

YIDU TECH (02158) experienced a significant surge in its stock price during the late trading session on Friday. The company's shares soared by 5.50%, demonstrating strong market interest in the AI healthcare firm.

The rally appears to be driven by YIDU TECH's recent participation in the prestigious "T20+ Conference" held in Suzhou. At the event, the company showcased its cutting-edge intelligent clinical research integrated solutions, highlighting the potential of AI in revolutionizing the drug development process. YIDU TECH's presentation focused on demonstrating replicable pathways for enhancing clinical research efficiency through AI technology, which seems to have resonated well with investors.

YIDU TECH's strong market position, serving over 350 domestic and international pharmaceutical companies and boasting experience from 686 clinical trial projects, likely contributed to investor confidence. The company's Vice President, Liu Ying, emphasized that their AI-powered solutions can accelerate key drug development stages by over 30%, potentially leading to significant cost reductions and faster product launches. This technological edge and its implications for the pharmaceutical industry appear to be the primary factors behind the stock's impressive performance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1180834139"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1180834139\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1180834139?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-15 16:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180834139","market":"sg","top_or_hot":-1,"title":"Stock Track | YIDU TECH Soars 5.50% as Company Showcases AI-Driven Clinical Research Solutions at T20+ Conference","media":"Stock Track","content":"<p>YIDU TECH (02158) experienced a significant surge in its stock price during the late trading session on Friday. The company's shares soared by 5.50%, demonstrating strong market interest in the AI healthcare firm.</p>\n\n<p>The rally appears to be driven by YIDU TECH's recent participation in the prestigious \"T20+ Conference\" held in Suzhou. At the event, the company showcased its cutting-edge intelligent clinical research integrated solutions, highlighting the potential of AI in revolutionizing the drug development process. YIDU TECH's presentation focused on demonstrating replicable pathways for enhancing clinical research efficiency through AI technology, which seems to have resonated well with investors.</p>\n\n<p>YIDU TECH's strong market position, serving over 350 domestic and international pharmaceutical companies and boasting experience from 686 clinical trial projects, likely contributed to investor confidence. The company's Vice President, Liu Ying, emphasized that their AI-powered solutions can accelerate key drug development stages by over 30%, potentially leading to significant cost reductions and faster product launches. This technological edge and its implications for the pharmaceutical industry appear to be the primary factors behind the stock's impressive performance.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | YIDU TECH Soars 5.50% as Company Showcases AI-Driven Clinical Research Solutions at T20+ Conference</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | YIDU TECH Soars 5.50% as Company Showcases AI-Driven Clinical Research Solutions at T20+ Conference\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-15 16:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>YIDU TECH (02158) experienced a significant surge in its stock price during the late trading session on Friday. The company's shares soared by 5.50%, demonstrating strong market interest in the AI healthcare firm.</p>\n\n<p>The rally appears to be driven by YIDU TECH's recent participation in the prestigious \"T20+ Conference\" held in Suzhou. At the event, the company showcased its cutting-edge intelligent clinical research integrated solutions, highlighting the potential of AI in revolutionizing the drug development process. YIDU TECH's presentation focused on demonstrating replicable pathways for enhancing clinical research efficiency through AI technology, which seems to have resonated well with investors.</p>\n\n<p>YIDU TECH's strong market position, serving over 350 domestic and international pharmaceutical companies and boasting experience from 686 clinical trial projects, likely contributed to investor confidence. The company's Vice President, Liu Ying, emphasized that their AI-powered solutions can accelerate key drug development stages by over 30%, potentially leading to significant cost reductions and faster product launches. This technological edge and its implications for the pharmaceutical industry appear to be the primary factors behind the stock's impressive performance.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02158","symbol_name":"医渡科技","start_time":0,"source_url":"","article_id":"1180834139","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180834139","pubTimestamp":1755245187,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"YIDU TECH (02158) experienced a significant surge in its stock price during the late trading session on Friday. The company's shares soared by 5.50%, demonstrating strong market interest in the AI...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02158":"医渡科技"},"translate_title":"个股追踪|医渡科技大涨5.50%公司在T20+会议上展示AI驱动的临床研究解决方案","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02158":1},"content_text":"YIDU TECH (02158) experienced a significant surge in its stock price during the late trading session on Friday. The company's shares soared by 5.50%, demonstrating strong market interest in the AI healthcare firm.\nThe rally appears to be driven by YIDU TECH's recent participation in the prestigious \"T20+ Conference\" held in Suzhou. At the event, the company showcased its cutting-edge intelligent clinical research integrated solutions, highlighting the potential of AI in revolutionizing the drug development process. YIDU TECH's presentation focused on demonstrating replicable pathways for enhancing clinical research efficiency through AI technology, which seems to have resonated well with investors.\nYIDU TECH's strong market position, serving over 350 domestic and international pharmaceutical companies and boasting experience from 686 clinical trial projects, likely contributed to investor confidence. The company's Vice President, Liu Ying, emphasized that their AI-powered solutions can accelerate key drug development stages by over 30%, potentially leading to significant cost reductions and faster product launches. This technological edge and its implications for the pharmaceutical industry appear to be the primary factors behind the stock's impressive performance.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}